Showing results 41 - 50 of 81
April 19, 2023, Paper: "Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had…
March 2023, Paper: "When there is an evidence base that could be used credibly to justify expedited US Food and Drug Administration review, emergency use authorization, or…
January 2023, Paper: "The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population uninsured. We suggest…
January 17, 2023, Paper: "In 2021, the Biden Administration issued mandates requiring COVID-19 vaccinations for U.S. federal employees and contractors and for some healthcare and…
January/February 2023, Interview: "For patients who depend on costly medications to stay healthy, co-pay coupons and patient assistance programs are popular ways to save money at…
December 2022, Paper: "Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information. The FDA’s…
December 8, 2022, Paper: "Hydroxyprogesterone caproate (Makena) is an injectable drug for the prevention of preterm birth, ie, birth prior to 37 weeks of gestation. About 1 in 10…
2022, Paper: "The U.S. healthcare system is undergoing a period of substantial change, with hospitals purchasing many physician practices (“vertical integration”). In theory, this…
November 4, 2022, Paper: "As the US Food and Drug Administration (FDA) embarks on historic regulatory actions that could fundamentally reshape the future of public health, chances…
September 2022, Paper: "The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs…